Reuters HealthA $1 billion fund backed by over 20 drugmakers made its first set of investments on April 4 in two biotechnology startups, nearly two years after it was launched to help struggling antibiotic makers tackle the threat of antibiotic-resistant bacteria.
Scientists have found multidrug-resistant “superbug” bacteria lurking on cash machines, escalators and handrails in London’s underground rail system, shopping centers and hospitals and say they pose a potential risk to public health.
Merck is globally committed to an antimicrobial stewardship encompassing surveillance, R&D, and health policy.
The CDC optimistically just said that better communication between hospitals, nursing homes, and health departments could markedly reduce antibiotic resistant “superbug” infections. While a laudable idea, I’m afraid the plan […]